NA
THTX

NewEdge Advisors’s Theratechnologies THTX Stock Holding History

NewEdge Advisors’s Portfolio THTX Stock Details THTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-6,250
Closed -$14.8K – 4247
2025
Q2 		$14.8K Hold
6,250
– – ﹤0.01% 3053
2025
Q1 		$8.75K Hold
6,250
– – ﹤0.01% 3147
2024
Q4 		$11.3K Sell
6,250
-36,213
-85% -$49.2K ﹤0.01% 2999
2024
Q3 		$52.7K Buy
42,463
+34,213
+415% +$46.4K ﹤0.01% 2414
2024
Q2 		$11.6K Hold
8,250
– – ﹤0.01% 2806
2024
Q1 		$13.7K Buy
8,250
+7,000
+560% +$11.2K ﹤0.01% 2761
2023
Q4 		$2.02K Hold
1,250
– – ﹤0.01% 3331
2023
Q3 		$2.69K Buy
+1,250
New +$2.68K ﹤0.01% 2982

Other funds holding THTX

JC
JBF Capital Aspen, Colorado $676M AUM 24.74% 1-Year Est. Return
Skandinaviska Enskilda Banken (SEB)
Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $4.34B AUM 19.31% 1-Year Est. Return
TC
Trium Capital London, United Kingdom $163M AUM 45.8% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
CWP
Cyndeo Wealth Partners St. Petersburg, Florida $1.9B AUM 24.89% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
GIP
Greatmark Investment Partners Columbus, Georgia $854M AUM 15.72% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $33.7B AUM 35.49% 1-Year Est. Return
GRP
Global Retirement Partners San Rafael, California $5.64B AUM

NewEdge Advisors's THTX Position: Q3 2025 in Review

NewEdge Advisors sold out of Theratechnologies (THTX) in Q3 2025, closing a stake of 6,250 shares — an estimated $14.8K sold.

NewEdge Advisors first reported a position in THTX in Q3 2023 and held it in 8 quarters. The position peaked at $52.7K in Q3 2024. 10 funds tracked by Wall St. Rank hold THTX as of Q3 2025.

  • NewEdge Advisors reported no remaining Theratechnologies position as of Q3 2025 after selling out during the quarter.
  • NewEdge Advisors sold 6,250 Theratechnologies shares in Q3 2025, an estimated $14.8K.
  • NewEdge Advisors first reported a position in Theratechnologies in Q3 2023 and held it in 8 quarters.
  • NewEdge Advisors's Theratechnologies position peaked at $52.7K in Q3 2024.
  • 10 funds tracked by Wall St. Rank held Theratechnologies as of Q3 2025.

Based on NewEdge Advisors's 13F filing for Q3 2025, filed 17 Nov 2025.